How should a 50‑year‑old woman at term with a twin pregnancy (IVF) and a history of multiple surgeries for wandering fibroids and two port‑site hernioplasties be managed when she presents with pregnancy‑induced hypertension (PIH), moderate low‑protein ascites, a large well‑circumscribed infra‑hepatic mass, and elevated cancer antigen 125 (CA 125)?

Immediate Delivery at Term with Multidisciplinary Surgical Planning

This patient requires immediate delivery via cesarean section given she is at term with twins, followed by urgent evaluation and likely surgical management of the infrahepatic mass during the same operative session or shortly thereafter.

Critical Clinical Context

This 50-year-old woman presents with a complex constellation of findings that demand urgent action:

• Term twin pregnancy (approximately 36+ weeks based on "starting of 8 months")
• Pregnancy-induced hypertension (PIH) requiring immediate management
• Large well-circumscribed infrahepatic mass with elevated CA-125
• Moderate ascites with low protein content
• Multiple prior abdominal surgeries creating significant surgical complexity

Immediate Hypertension Management

The PIH must be addressed urgently before any surgical intervention 1, 2:

• If blood pressure ≥160/110 mmHg: This constitutes a hypertensive emergency requiring treatment within 30-60 minutes with:

  • First-line: Oral nifedipine or intravenous labetalol 1, 2
  • Intravenous hydralazine is acceptable but associated with more perinatal adverse effects 3

• If blood pressure 140-159/90-109 mmHg: Initiate oral antihypertensives (methyldopa, labetalol, or nifedipine) 2, 4

• Magnesium sulfate should be administered for seizure prophylaxis if severe hypertension or proteinuria is present 2

Critical caveat: Do NOT give magnesium sulfate concomitantly with calcium channel blockers due to risk of severe hypotension 1.

Delivery Timing and Approach

Delivery should occur immediately for multiple compelling reasons 2:

1. Term gestation with twins: The patient has reached appropriate gestational age (≥37 weeks is considered term for delivery in preeclampsia) 2
2. PIH at term: Delivery is the definitive treatment for pregnancy-induced hypertension 5, 4
3. Need for definitive diagnosis of the mass: The pregnancy is preventing optimal evaluation and treatment of a potentially malignant process

Route of delivery: Cesarean section is strongly indicated given:

• Twin gestation
• Multiple prior abdominal surgeries with adhesions
• Need for concurrent or staged evaluation of the infrahepatic mass
• Likely need for comprehensive abdominal exploration

The Infrahepatic Mass: Diagnostic Approach

The combination of elevated CA-125 + ascites + pelvic/abdominal mass raises significant concern for ovarian malignancy, though CA-125 interpretation in pregnancy requires caution:

Important considerations:

• CA-125 is physiologically elevated in pregnancy and should not be used for routine management 6
• However, CA-125 levels correlate with preeclampsia severity 7, 8, and markedly elevated levels (particularly >100 U/mL) warrant concern for malignancy
• Low-protein ascites in this context could represent either:
  • Severe preeclampsia with capillary leak
  • Malignant ascites (ovarian cancer classically produces low-protein ascites)
  • Peritoneal carcinomatosis

The "wandering fibroids" history is crucial: This suggests either:

• Parasitic fibroids (fibroids that have detached and developed alternative blood supply)
• Misdiagnosed ovarian masses in prior surgeries
• True fibroids that have undergone degeneration

Surgical Planning Algorithm

Step 1: Immediate Preoperative Workup (Within Hours)

• Complete blood count, comprehensive metabolic panel, liver function tests
• Coagulation studies (PT/INR, PTT, fibrinogen) - essential given PIH risk of HELLP syndrome
• Type and cross-match at least 4 units packed red blood cells
• Anesthesia consultation for high-risk case
• Neonatology team on standby for twin delivery

Step 2: Cesarean Section with Intraoperative Assessment

• Perform cesarean delivery via vertical skin incision (given multiple prior surgeries and need for potential extension)
• Carefully inspect the entire abdomen and pelvis after delivery of twins and placenta
• Obtain ascitic fluid for:
  • Cytology (malignant cells?)
  • Cell count and differential
  • Protein, LDH, glucose
  • Culture if infection suspected
• Visually characterize the infrahepatic mass:
  • Solid vs. cystic
  • Smooth vs. irregular surface
  • Vascular pattern
  • Relationship to liver, gallbladder, right kidney, hepatic flexure
  • Any peritoneal implants suggesting carcinomatosis

Step 3: Intraoperative Decision Tree

If mass appears benign (smooth, encapsulated, consistent with degenerating fibroid):

• Consider frozen section biopsy
• If frozen section benign and patient stable: close and plan interval surgery in 6-8 weeks postpartum
• Document size and location for postpartum follow-up

If mass appears suspicious for malignancy (irregular, fixed, peritoneal implants, bloody ascites):

• Obtain frozen section immediately
• If frozen section confirms malignancy:
  • Gynecologic oncology should perform staging (if available intraoperatively)
  • If not available: obtain biopsies, document extent of disease, close
  • Definitive staging surgery within 2-4 weeks postpartum
• If frozen section indeterminate: close and expedite final pathology

If patient becomes hemodynamically unstable:

• Control hemorrhage
• Complete cesarean delivery
• Defer mass evaluation
• Plan staged procedure after stabilization

Postpartum Management

Immediate Postpartum (First 24-48 Hours)

• Continue antihypertensive therapy: Transition to postpartum-safe agents (nifedipine, amlodipine, enalapril, or labetalol) 9
• Monitor blood pressure closely: 10% of maternal deaths from hypertensive disorders occur postpartum 1
• Monitor for postpartum preeclampsia complications (stroke, pulmonary edema, seizures)
• Serial hemoglobin checks given surgical complexity

Definitive Mass Evaluation (Within 1 Week)

If mass not fully evaluated intraoperatively:

• MRI abdomen/pelvis without gadolinium (safe if breastfeeding) to characterize mass
• Tumor markers: Repeat CA-125, add CEA, CA 19-9, AFP (now interpretable postpartum)
• Multidisciplinary tumor board discussion (gynecologic oncology, surgical oncology, hepatobiliary surgery)

Timing of Definitive Surgery

• If malignancy confirmed: Staging surgery within 2-4 weeks postpartum
• If benign but symptomatic: Elective removal at 6-8 weeks postpartum
• If benign and asymptomatic: Can consider observation with serial imaging

Critical Pitfalls to Avoid

1. Do NOT delay delivery to further evaluate the mass - the pregnancy prevents optimal imaging and the patient is at term
2. Do NOT assume elevated CA-125 equals cancer - it correlates with preeclampsia severity 7
3. Do NOT attempt definitive cancer surgery at cesarean section unless gynecologic oncology is immediately available and patient is stable
4. Do NOT give magnesium sulfate with calcium channel blockers - risk of severe hypotension 1
5. Do NOT use ACE inhibitors during pregnancy - switch immediately postpartum if needed 4, 10

Contraception Counseling

Before hospital discharge, provide contraception counseling and documented plan, particularly if angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers will be used for blood pressure control given teratogenicity risk 9.

This approach prioritizes maternal mortality risk (stroke from uncontrolled hypertension, hemorrhage from surgery, potential malignancy) while ensuring fetal wellbeing (delivery at appropriate gestational age) and quality of life (definitive diagnosis and treatment of the mass).